Figure 1
Figure 1. Disposition of pediatric patients with ITP of at least 6 months' duration who were treated with placebo or romiplostim for up to 16 weeks.

Disposition of pediatric patients with ITP of at least 6 months' duration who were treated with placebo or romiplostim for up to 16 weeks.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal